Maple Valley - Anthon Oto Csd Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 110 W Division St, Anthon, IA 51004 Phone: 712-373-5246 Fax: 712-373-5326 |
News Archive
A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.
GlobalPost's "Global Pulse" blog summarizes a recent forum on reproductive health issues during which panel members of the Global Leaders Council for Reproductive Health of Aspen Global Health and Development discussed how "reproductive health was intimately connected to the world's population boom, climate change, water and sanitation crises, economic downturns, educational rates, and development overall." The article continues, "And yet, reproductive health and family planning is generally not a focus on the world stage.
A team of Japanese researchers have developed a new compound that enhanced motor function recovery after brain damage in animal tests, according to a study published in the journal Science.
Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer's disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer and Janssen Alzheimer Immunotherapy, a Johnson & Johnson subsidiary in which Elan holds a minority equity interest.
› Verified 1 days ago